, ? . . healthline 6 . 1. , . , . , , , , . 2~4, 30 .2. . , . (HY7601) (KY1032) , . , . . 3. · . Q&A , , , , 20~40 . . , . 3 10 3, 10 3, 20 3 . 4. . , , . , . , 100g . 5. . 2019 (BMC Public … [+132 chars]
. 6 10 . : . C , . . : . . . : . ‘ ’ . . : . , . . , , : , , . , , . . : . . . : , . . . . . , , , , , , .
--() 2022 05 30 -- , . . , , , . , . , , . ( ) . - () Ph. D. , - (1983~2011) - (1993~1994) (KEK) 20 (PS E307, E508, Jparc E18) PRL (Physical Review Letters) SCI - : ( ) . , 3 (PS E508 ) PR… [+320 chars]
[= ] 5 29 (WGO·World Gastroenterology Organisation) (5 29), . . , . . . 2011 . , . · . . . · · . . 90% . , . , . (2015) , . gorgeous@heraldcorp.com
HIV ' ' . HIV (pre-exposure prophylaxis, 'PrEP') . PrEP HIV . 2016 PrEP HIV , 2012 PrEP 3 44% . PrEP 2018 . 5 PrEP 'HIV ' . HIV 'MSM(Man who have sex with Man; )' . PrEP '' 13,150 40 .… [+760 chars]
[] (IVI) 3640, , IVI(KSC) 27 (OCV) 30 . , IVI LG 4 2 . 10 , . IVI () - . 2017 WHO (PQ) , . - (WHO) OCV 20 6000 . IVI (ECCP-KSC), LG ECCP-LG OCV . ECCP-KSC IVI 6 , 2 . 3640, , , , , 72 , , , , … [+120 chars]
. () ‘’ . .(MRI) , . , . T . , . 1 , 2 . 1 . , ‘PLA2G7( ‘ )’ . 35g 5~25g . . T ‘1(Thymosin α)’ . 1 28 . T , , . ‘ ’ . 1 . 1() . '() (1988)' , NK 4 (NK , CD8+, CD4+, Th1) . Copyright Acrofan All… [+15 chars]
. 6 7 9 . 8 . 7 5 5 . 7 . . . . . . . . . . . . . , . 5 , 1 22 . . . . . 10 5 9% . 3 . . . 2, 10 . , , , . , . . . . . . 5 . . . , . . . . . . . . 19 . 7 … [+450 chars]
() . 3~7% . , 46~70% . 10mm , . , 10mm . 3~8% . . . , . . . . . , . , . . 10mm . , 50 10mm . . . 10mm . 1~2 3~6 6~12 .
[=] , 184000 . , , , , . 133000 45000, 6450 . , · . . . . . 7. [=] , . . , 11 . () . . [=] 2 80% . 2 . . . . . [=] 70% . . . . … [+81 chars]
. . , 40% 2021 2019 29030 . 11.4% , , 4 . 11828, 4.6%. 7554, 4274. 60 26.8% , 50 23.0%, 70 21.4% . 40% . . . , . 1 . . 20~50% . 1~2, 60~80% 2 . 90% 3~5 , 5 . 1 . , . 2 . . 45 5~10 . . , , … [+34 chars]
[= ] 19 . 19 (Journal of American Chemical Society) . 19 , . . , , , , 2 , . . . , . , . , . , . , . , 19 . (hanjh3438@mdtoday.co.kr) [ . - ]
